Related Experiment Video
Updated: Feb 26, 2026
07:45
Severe Burn Injury in a Swine Model for Clinical Dressing Assessment
Published on: November 6, 2018
10.3K
Moist exposed burn ointment for treating pressure ulcers: A multicenter randomized controlled trial
1Department of Medical Science Institute of Harbin, the First Hospital of Harbin, Harbin Medical University, Harbin Department of Orthopedics, Hongqi Hospital of Mudanjiang Medical College, Mudanjiang Department of Study Center, the First Affiliated Hospital of Harbin Medical University, Harbin, China.
Medicine
|July 21, 2017
Summary
Moist Exposed Burn Ointment (MEBO) significantly improved wound healing in Chinese patients with pressure ulcers compared to placebo. This treatment demonstrated effectiveness and good tolerability for pressure ulcer management.
Area of Science:
- Dermatology
- Wound Healing Research
- Clinical Trials
Background:
- Pressure ulcers significantly impair patient quality of life.
- Moist Exposed Burn Ointment (MEBO) is a therapeutic agent for pressure ulcers.
- Evaluating MEBO's efficacy and safety in Chinese patients is crucial.
Purpose of the Study:
- To assess the efficacy and safety of MEBO for treating pressure ulcers.
- To compare MEBO's effectiveness against a placebo in a clinical trial.
- To determine MEBO's impact on wound healing metrics.
Main Methods:
- A randomized controlled trial involving 72 patients with pressure ulcers.
- Patients were assigned to receive either MEBO or a placebo for 2 months.
- Primary outcomes included wound surface area (WSA) and the Pressure Ulcer Scale for Healing (PUSH) tool; secondary outcomes included VAS and ulcer status questionnaires.
Main Results:
- MEBO treatment resulted in significantly greater reductions in WSA, PUSH scores, and VAS scores compared to placebo.
- Fifty percent of patients receiving MEBO achieved complete healing, versus 16.7% in the placebo group (P < .05).
- No major adverse effects were reported in either treatment group.
Conclusions:
- MEBO is an effective treatment for improving wound healing in Chinese patients with pressure ulcers.
- MEBO demonstrates good tolerability, making it a viable option for pressure ulcer management.
- The study supports the use of MEBO in clinical practice for pressure ulcer care.
